Incyte Corp - Company Profile
Powered by 
All the sales intelligence you need on Incyte Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Incyte Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Incyte Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Incyte Corp patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11833152B2 | Grant | Jak1 pathway inhibitors for the treatment of cytokine-related disorders | A61K31/4155; A61K31/437; A61K31/519; A61K31/573; A61P37/00; A61P37/02; C07K16/2866 | December 05, 2023 |
| US11833155B2 | Grant | Combination therapy for treatment of myeloproliferative neoplasms | A61K31/519; A61K31/538; A61P35/00 | December 05, 2023 |
| CN117157080A | Application | 用于治疗皮肤病的含维生素d类似物的jak抑制剂 | December 01, 2023 | |
| CN114010611B | Grant | Jak1抑制剂的持续释放剂型 | A61K31/519; A61K9/2009; A61K9/2013; A61K9/2018; A61K9/2031; A61K9/2054; A61K9/2059; A61P1/04; A61P13/12; A61P17/00; A61P17/02; A61P17/04; A61P17/06; A61P19/02; A61P19/08; A61P19/10; A61P21/04; A61P25/00; A61P25/28; A61P29/00; A61P3/10; A61P35/00; A61P35/02; A61P37/00; A61P37/06; A61P37/08; A61P43/00; A61P5/14; A61P5/50; A61P7/00; A61P7/06; A61P9/00 | November 28, 2023 |
| LT3786162T | Grant | Bipyrazole derivatives as jak inhibitors | A61K31/4155; A61P29/00; A61P35/00; A61P37/00; A61P37/06; C07B2200/13; C07D401/14; C07D403/14 | November 27, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer